graduation at Ciencias Biológicas Modalidade Médica from Centro Universitário Barão de Mauá - Jardim Paulista (1997), master's at Applied Imunology from Universidade de São Paulo (2001) and doctorate at Imunologia Básica e Aplicada from Universidade de São Paulo (2005). He is currently professor adjunto i at Universidade Federal de São Carlos. Has experience in Parasitology, focusing on Parasitology, acting on the following subjects: parasitas, inflamação, epidemiologia, leucocitos and eosinófilos. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The model for evaluating the activity of Schistosma mansoni recombinant proteins will be the type 2 Diabetes mellitus (DM2) model, one of the diseases classified as metabolic syndrome, commonly associated with obesity and sedentary lifestyle. In addition, due to the change in the action of insulin, DM2 causes severe hyperglycemia to the carrier, which in turn predisposes to pathological c…
Schistosomiasis is a parasitic disease caused by blood worms of the genus Schistosoma and it is estimated that over 249 million people are affected worldwide. The limited amount of drugs used to treat the development of resistance to existing anthelmintics suggests priority in the development of new drugs. The murine model has been used extensively to study the immunopathology of the dise…
Schistosomiasis is considered the most important of the human helminthiasis in terms of morbidity and mortality, caused by Schistosoma mansoni, a blood vascular system helminth. Despite major advances in its control, schistosomiasis continues to spread to new geographic areas. Currently, schistosomiasis affects more than 250 million people. There are limited options available for the chem…
Studies in the area of inflammation and metabolism have linked the development of obesity and diabetes with the increase of pro-inflammatory markers, characterizing a low-grade chronic inflammation state, mainly in adipose and liver tissue. Another important aspect has shown that molecules that have immunomodulatory activity can present therapeutic activity, in the control of metabolic dy…
Schistosomiasis mansoni, a disease that affects more than 240 million people worldwide, is caused by a trematode, Schistosoma mansoni. Among tropical diseases, it ranks second in mortality in the world, second only to malaria. The developed inflammatory response is not yet fully understood and the parasite control measures are deficient, which can lead to environmental and population dama…
Schistosomiasis is one of the most prevalent tropical infectious diseases. Endemic in 78 countries, it is estimated that 240 million people have been infected and over 700 million reside in risk areas. Much of the morbidity and mortality associated with this helminthiasis is directly attributed principally to the deposition of eggs and their antigens affected tissues. The use of Praziquan…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing research grants |
| 10 / 3 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 18 / 14 | Completed scholarships in Brazil |
| 30 / 19 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID